Genomic Cancer Testing: See The Real Picture of a Cancer Diagnosis
- Health at Bayer
Treatments & Therapies
- Chronic Kidney Disease
- Eye Conditions
- Healthy Aging
- Hormonal & Reproductive Health
Innovation & Technologies
- Patient Access Charter
- Leadership Perspective
- Strengthening Healthcare Access
- Empowering Women, Globally
- Fighting Neglected Tropical Diseases
- Moving Non-Communicable Diseases Care Forward
- Ensuring a Sustainable Product Supply
- Delivering Better Cancer Care
- News & Stories
- Clinical Trials Explorer
- Transparency Policy
- Treatments & Therapies
- Our Commitments
- Report a Side Effect
- Medical Counterfeits
We are used to hearing about cancer treatments in relation to a specific part of the body such as the breast, lung or prostate. But recently, there has been a paradigm shift in how we approach cancer treatment – towards precision medicine, which is tailored to each individual.
Understanding Genomic Cancer Testing & Precision Medicine
Genomic cancer testing harnesses the power of precision medicine and can paint a more precise picture of a cancer diagnosis. It’s used to identify different changes in DNA known as alterations within cancer cells that determine how a tumor behaves or why it grows. This knowledge offers doctors a way to recommend more targeted treatments earlier and reduce the number of treatments patients may try.
A Gap in Knowledge
Genomic cancer testing is often mistaken for genetic testing, which looks at inherited genes, or not discussed at all by patients and doctors alike. Yet, genomic cancer testing can personalize cancer care by helping patients and their doctors better understand their diagnosis and reveal specific cancer drivers.
For cancer patients, it’s important to have a better understanding of what drives their cancer. The results can lead to treatment options that are tailored specifically for each person’s cancer.